Clas Rehnberg
Clas Rehnberg
Verified email at
Cited by
Cited by
Cost of depression in Europe.
P Sobocki, B Jönsson, J Angst, C Rehnberg
The journal of mental health policy and economics 9 (2), 87-98, 2006
Costs and quality of life associated with osteoporosis-related fractures in Sweden
F Borgström, N Zethraeus, O Johnell, L Lidgren, S Ponzer, O Svensson, ...
Osteoporosis international 17, 637-650, 2006
Health related quality of life in different states of breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
Quality of life research 16, 1073-1081, 2007
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
F Borgström, O Johnell, JA Kanis, B Jönsson, C Rehnberg
Osteoporosis international 17, 1459-1471, 2006
Internal markets and health care efficiency: a multiple‐output stochastic frontier analysis
UG Gerdtham, M Löthgren, M Tambour, C Rehnberg
Health economics 8 (2), 151-164, 1999
The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals
Q Meng, G Cheng, L Silver, X Sun, C Rehnberg, G Tomson
Health Policy and Planning 20 (3), 185-196, 2005
The impact of internal markets on health care efficiency: evidence from health care reforms in Sweden
UG Gerdtham, C Rehnberg, M Tambour
Applied Economics 31 (8), 935-945, 1999
How are individual-level social capital and poverty associated with health equity? A study from two Chinese cities
X Sun, C Rehnberg, Q Meng
International Journal for Equity in Health 8, 1-13, 2009
Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer
M Lidgren, B Jönsson, C Rehnberg, N Willking, J Bergh
Annals of oncology 19 (3), 487-495, 2008
Health care performance comparison using a disease-based approach: the EuroHOPE project
U Häkkinen, T Iversen, M Peltola, TT Seppälä, A Malmivaara, É Belicza, ...
Health Policy 112 (1-2), 100-109, 2013
Deteriorating health status in Stockholm 1998–2002: results from repeated population surveys using the EQ-5D
K Burström, M Johannesson, C Rehnberg
Quality of Life Research 16, 1547-1553, 2007
Economic impact of adverse drug events–a retrospective population-based cohort study of 4970 adults
H Gyllensten, KM Hakkarainen, S Hägg, A Carlsten, M Petzold, ...
PloS one 9 (3), e92061, 2014
Resource use and costs associated with different states of breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
International journal of technology assessment in health care 23 (2), 223-231, 2007
Drug policy in China: pharmaceutical distribution in rural areas
H Dong, L Bogg, C Rehnberg, V Diwan
Social science & medicine 48 (6), 777-786, 1999
Measuring cost efficiency in the Nordic Hospitals—a cross-sectional comparison of public hospitals in 2002
M Linna, U Häkkinen, M Peltola, J Magnussen, KS Anthun, S Kittelsen, ...
Health care management science 13, 346-357, 2010
Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
Acta Oncologica 47 (6), 1018-1028, 2008
Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis
E Medin, KS Anthun, U Häkkinen, SAC Kittelsen, M Linna, J Magnussen, ...
The European journal of health economics 12, 509-519, 2011
Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey
H Gyllensten, C Rehnberg, AK Jönsson, M Petzold, A Carlsten, ...
BMJ open 3 (6), e002574, 2013
A description of outpatient drug use in rural China: evidence of differences due to insurance coverage
H Dong, L Bogg, K Wang, C Rehnberg, V Diwan
The International Journal of Health Planning and Management 14 (1), 41-56, 1999
The impact of urban health insurance reform on hospital charges: a case study from two cities in China
Q Meng, C Rehnberg, N Zhuang, Y Bian, G Tomson, S Tang
Health Policy 68 (2), 197-209, 2004
The system can't perform the operation now. Try again later.
Articles 1–20